Cargando…
Chronic Hepatitis E Virus Infection during Lymphoplasmacytic Lymphoma and Ibrutinib Treatment
Hepatitis E virus (HEV) is an increasingly recognised pathogen, affecting several hundred thousand individuals in western countries each year. Importantly, the majority of immunocompromised individuals are not able to clear HEV but develop a chronic course of infection. In the case of lymphoma, whic...
Autores principales: | Schlevogt, Bernhard, Kinast, Volker, Reusch, Julia, Kerkhoff, Andrea, Praditya, Dimas, Todt, Daniel, Schmidt, Hartmut H., Steinmann, Eike, Behrendt, Patrick |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6789582/ https://www.ncbi.nlm.nih.gov/pubmed/31443360 http://dx.doi.org/10.3390/pathogens8030129 |
Ejemplares similares
-
The natural compound silvestrol inhibits hepatitis E virus (HEV) replication in vitro and in vivo
por: Todt, Daniel, et al.
Publicado: (2018) -
Ibrutinib response in cutaneous transformed lymphoplasmacytic lymphoma
por: Lindholm, Kaleigh E., et al.
Publicado: (2021) -
Hepatitis E Virus Drug Development
por: Kinast, Volker, et al.
Publicado: (2019) -
Robust hepatitis E virus infection and transcriptional response in human hepatocytes
por: Todt, Daniel, et al.
Publicado: (2020) -
Influence of Tattoo Ink on Hepatitis C Virus Infectiousness
por: Behrendt, Patrick, et al.
Publicado: (2019)